Agency Information Collection Activities: Submission for OMB Review; Comment Request, 28554-28556 [2023-09400]
Download as PDF
28554
Federal Register / Vol. 88, No. 86 / Thursday, May 4, 2023 / Notices
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10398 #59]
Medicaid and Children’s Health
Insurance Program (CHIP) Generic
Information Collection Activities:
Proposed Collection; Comment
Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
On May 28, 2010, the Office
of Management and Budget (OMB)
issued Paperwork Reduction Act (PRA)
guidance related to the ‘‘generic’’
clearance process. Generally, this is an
expedited process by which agencies
may obtain OMB’s approval of
collection of information requests that
are ‘‘usually voluntary, low-burden, and
uncontroversial collections,’’ do not
raise any substantive or policy issues,
and do not require policy or
methodological review. The process
requires the submission of an
overarching plan that defines the scope
of the individual collections that would
fall under its umbrella. On October 23,
2011, OMB approved our initial request
to use the generic clearance process
under control number 0938–1148
(CMS–10398). It was last approved on
April 26, 2021, via the standard PRA
process which included the publication
of 60- and 30-day Federal Register
notices. The scope of the April 2021
umbrella accounts for Medicaid and
CHIP State plan amendments, waivers,
demonstrations, and reporting. This
Federal Register notice seeks public
comment on one or more of our
collection of information requests that
we believe are generic and fall within
the scope of the umbrella. Interested
persons are invited to submit comments
regarding our burden estimates or any
other aspect of this collection of
information, including: the necessity
and utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
Comments must be received by
May 17, 2023.
DATES:
VerDate Sep<11>2014
17:12 May 03, 2023
Jkt 259001
When commenting, please
reference the applicable form number
(CMS–10398 #59) and the OMB control
number (0938–1148). To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address:
CMS, Office of Strategic Operations
and Regulatory Affairs, Division of
Regulations Development, Attention:
CMS–10398 #59/0938–1148, Room C4–
26–05, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
regulations-and-guidance/legislation/
paperworkreductionactof1995/pralisting.
ADDRESSES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
the goals for the demonstrations. To
improve the quality and efficiency of
the reporting requirements, CMS in
conjunction with state advisory groups
developed a set of standardized
monitoring tools for states to use for
their regular reporting. In this 2023
collection of information request, States
continue to use our currently approved
reporting tools. As part of the metaanalysis, we also propose to add virtual
interviews with behavioral health
providers in states that have approved
section 1115 SMI demonstrations. Our
burden estimates have been updated to
account for changes in the tools and the
virtual interviews with behavioral
health providers. Form Number: CMS–
10398 #59 (OMB control number: 0938–
1148); Frequency: Yearly, quarterly, and
once; Affected Public: State, Local, or
Tribal Governments; Number of
Respondents: 15; Total Annual
Responses: 282; Total Annual Hours:
3,725. For policy questions regarding
this collection contact Danielle Daly at
443–379–3289.
Dated: May 1, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2023–09511 Filed 5–3–23; 8:45 am]
BILLING CODE 4120–01–P
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
Following
is a summary of the use and burden
associated with the subject information
collection(s). More detailed information
can be found in the collection’s
supporting statement and associated
materials (see ADDRESSES).
SUPPLEMENTARY INFORMATION:
Generic Information Collection
1. Title of Information Collection:
Medicaid Section 1115 Severe Mental
Illness and Children with Serious
Emotional Disturbance Demonstrations;
Type of Information Collection Request:
Revision of an existing generic
information collection request; Use:
States with approved serious mental
illness (SMI) demonstrations are
required to develop implementation and
monitoring plans, including monitoring
metrics, monitoring protocol, regular
monitoring reports describing their
implementation progress, and
availability assessments. In addition, the
Medicaid Section 1115 demonstration
monitoring and evaluation Special
Terms and Conditions specify that states
are required to submit in their regular
monitoring reports, information on
milestones and performance measures
that they elected to represent key
indicators of progress toward meeting
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–855A, CMS–R–
246 and CMS–10823]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
SUMMARY:
E:\FR\FM\04MYN1.SGM
04MYN1
Federal Register / Vol. 88, No. 86 / Thursday, May 4, 2023 / Notices
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Comments on the collection(s) of
information must be received by the
OMB desk officer by June 5, 2023.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
DATES:
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Reinstatement with change of a
previously approved collection; Title of
Information Collection: Medicare
ddrumheller on DSK120RN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:12 May 03, 2023
Jkt 259001
Enrollment Application for Institutional
Providers; Use: The primary function of
the CMS–855A Medicare enrollment
application is to gather information
from a certified provider or certified
supplier (hereafter occasionally and
collectively referenced as ‘‘provider(s)’’)
that tells us who it is, whether it meets
certain qualifications to be a health care
provider, where it practices or renders
services, the identity of its owners, and
other information necessary to establish
correct claims payments. This collection
of information reinstatement request is
associated in part with our December
28, 2020 (85 FR 84472) final rule (CMS–
1734–F, RIN 0938–AU10). The
collection of information changes
stemming from this final rule were
approved by OMB on September 28,
2021 (ICR Reference No.: 202103–0938–
010).
Existing § 424.67 outlines a number of
enrollment requirements for opioid
treatment programs (OTPs). One
requirement, addressed in
§ 424.67(b)(1)(i), is that OTPs must
maintain and submit to CMS a list of all
physicians, other eligible professionals,
and pharmacists who are legally
authorized to prescribe, order, or
dispense controlled substances on the
OTP’s behalf; the list must include the
person’s first and last name and middle
initial, social security number, National
Provider Identifier, and license number
(if applicable). This reinstatement
request will add these data elements to
the CMS–855A, which OTPs must
complete if they wish to bill for OTP
services via an institutional claim form
(specifically, the 837I).
On November 23, 2022, CMS
published in the Federal Register a final
rule with comment period rule titled
‘‘Medicare Program: Hospital Outpatient
Prospective Payment and Ambulatory
Surgical Center Payment Systems and
Quality Reporting Programs; Organ
Acquisition; Rural Emergency Hospitals:
Payment Policies, Conditions of
Participation, Provider Enrollment,
Physician Self-Referral; New Service
Category for Hospital Outpatient
Department Prior Authorization Process;
Overall Hospital Quality Star Rating;
COVID–19’’ (CMS–1772–FC) (87 FR
71748). This final rule with comment
period outlined requirements that rural
emergency hospitals (REHs)—a new
Medicare provider type established
pursuant to Section 125 of Division CC
of the Consolidated Appropriations Act,
2021—must meet in order to bill
Medicare for REH services; in
accordance with new section 1861(kkk)
of the Social Security Act, a facility is
eligible to convert to an REH if it was
a critical access hospital (CAH) or rural
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
28555
hospital with less than 50 beds as of
December 27, 2020. CMS–1772–FC’s
REH requirements include those
necessary to enroll as an REH. The most
pertinent of these is that a CAH or rural
hospital seeking REH enrollment
submits a CMS–855A change of
information application and need not
submit a full, initial CMS–855A
application. This reinstatement request
will address the expected REH burden
associated with completing these CMS–
855A changes of information.
As part of this request, and as
described in the supporting statement,
we also seek approval for additional
changes to the CMS–855A. These
changes principally (though not
exclusively) involve the collection of
information related to the provider’s
ownership.
Form Number: CMS–855A (OMB
control number: 0938–0685); Frequency:
On occasion; Affected Public: Business
or other for-profits, not-for-profit
institutions; Number of Respondents:
1,340; Total Annual Responses: 5,881;
Total Annual Hours: 72,147. (For policy
questions regarding this collection
contact Frank Whelan at 410–786–
1302.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare
Advantage, Medicare Part D, and
Medicare Fee-For-Service Consumer
Assessment of Healthcare Providers and
Systems (CAHPS) Survey; Use: CMS is
required to collect and report
information on the quality of health care
services and prescription drug coverage
available to persons enrolled in a
Medicare health or prescription drug
plan under provisions in the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA).
Specifically, the MMA under Sec.
1860D–4 (Information to Facilitate
Enrollment) requires CMS to conduct
consumer satisfaction surveys regarding
Medicare prescription drug plans and
Medicare Advantage plans and report
this information to Medicare
beneficiaries prior to the Medicare
annual enrollment period. The Medicare
CAHPS survey meets the requirement of
collecting and publicly reporting
consumer satisfaction information. The
Balanced Budget Act of 1997 also
requires the collection of information
about fee-for-service plans.
The primary purpose of the Medicare
CAHPS surveys is to provide
information to Medicare beneficiaries to
help them make more informed choices
among health and prescription drug
plans available to them. Survey results
are reported by CMS in the Medicare &
E:\FR\FM\04MYN1.SGM
04MYN1
ddrumheller on DSK120RN23PROD with NOTICES1
28556
Federal Register / Vol. 88, No. 86 / Thursday, May 4, 2023 / Notices
You Handbook published each fall and
on the Medicare Plan Finder website.
Beneficiaries can compare CAHPS
scores for each health and drug plan as
well as compare MA and FFS scores
when making enrollment decisions. The
Medicare CAHPS also provides data to
help CMS and others monitor the
quality and performance of Medicare
health and prescription drug plans and
identify areas to improve the quality of
care and services provided to enrollees
of these plans. CAHPS data are included
in the Medicare Part C & D Star Ratings
and used to calculate MA Quality Bonus
Payments. Form Number: CMS–R–246
(OMB control number: 0938–0732);
Frequency: Yearly; Affected Public:
Individuals and Households; Number of
Respondents: 794,500; Total Annual
Responses: 794,500; Total Annual
Hours: 192,265. (For policy questions
regarding this collection contact Lauren
Fuentes at 410–786–2290).
3. Type of Information Collection
Request: New collection (Request for
new OMB control number); Title of
Information Collection: End-stage Renal
Disease (ESRD) Quality Incentive
Program (QIP): Study of Quality and
Patient Experience; Use: The Centers for
Medicare & Medicaid Services (CMS)
oversees the quality of care provided by
dialysis facilities by administering the
Quality Incentive Program (QIP). As part
of the evaluation of this program, CMS
seeks to gain a deeper understanding of
emerging trends observed across the
dialysis landscape by conducting
qualitative data collection and analysis.
These primary qualitative data
collection activities seek to answer the
following research questions related to
dialysis quality, access to care, health
equity, and quality of life:
1. What aspects of patient dialysis
care do patients report as a priority?
2. How, if at all, do dialysis facilities
evaluate the quality of care they
provide?
3. What strategies do providers and
dialysis facilities use to improve access
to care for underserved populations?
4. What do patients, providers, and
stakeholder organizations believe
contributes to high quality of life for
patients with ESRD? Do perceptions
vary by respondent type or respondent
characteristics?
5. How do dialysis facilities measure
patient satisfaction and quality of life?
6. How do dialysis providers and
stakeholder organizations think quality
of life for dialysis patients has changed
over time? What was the impetus for
that change?
We are requesting to collect
information through in depth interviews
with stakeholders of the CMS end-stage
VerDate Sep<11>2014
17:12 May 03, 2023
Jkt 259001
renal disease (ESRD) Quality Incentive
Program (QIP). The interviews will
collect data from individuals with
ESRD, dialysis facility administrators,
dialysis social workers, transplant
center administrators, corporate
representatives from dialysis
organizations, and patient advocacy
organizations.
This data collection seeks to answer
several research questions specific to
health outcomes for dialysis patients, as
measured by the QIP, that are not
available through current literature or
secondary data collection. In
preparation for this study, the
evaluation team conducted a scan of
peer-reviewed literature and document
review of previous ESRD QIP
monitoring and evaluation reports and
policy documents describing CMS
priorities. Based on the results from this
scan, the study team identified
persistent knowledge gaps and
opportunities for primary data
collection. Drawing on high-quality
data, empirical rigor, and knowledge of
nonprogrammatic factors, the evaluation
will benefit CMS by providing datadriven findings and recommendations
to improve patient care, reduce health
disparities, and promote health equity.
This primary data collection will
allow CMS to more comprehensively
understand the data being compiled and
analyzed quantitatively and will
provide more context related to dialysis
quality, quality of life of individuals
with ESRD, access to dialysis care, and
the patient experience, which are
current CMS priorities. Form Number:
CMS–10823 (OMB control number:
0938–NEW); Frequency: Once; Affected
Public: Private Sector (Business or other
for-profits, Not-for-Profit Institutions),
Individuals and Households; Number of
Respondents: 1,945; Total Annual
Responses: 1,945; Total Annual Hours:
604. (For policy questions regarding this
collection contact Christopher King at
(410) 786–6972).
Dated: April 28, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2023–09400 Filed 5–3–23; 8:45 am]
BILLING CODE 4120–01–P
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review; 2024
National Survey of Early Care and
Education (OMB #: 0970–0391)
Office of Planning, Research,
and Evaluation, Administration for
Children and Families, U.S. Department
of Health and Human Services.
ACTION: Request for public comments.
AGENCY:
The Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is proposing a data
collection activity as part of the 2024
National Survey of Early Care and
Education (NSECE) to be conducted
October 2023 through July 2024. The
objective of the 2024 NSECE is to
document the nation’s use and
availability of early care and education
(ECE) services, building on the
information collected in 2012 and 2019
to describe the ECE landscape in the
U.S. The 2024 NSECE will collect
information on families with children
under age 13 years, on ECE providers
that serve families with children from
birth to 13 years in the U.S., and on the
workforce providing these services.
DATES: Comments due within 30 days of
publication. The Office of Management
and Budget (OMB) must make a
decision about the collection of
information between 30 and 60 days
after publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing
OPREinfocollection@acf.hhs.gov.
Identify all requests by the title of the
information collection.
SUPPLEMENTARY INFORMATION:
Description: The 2024 NSECE will
consist of four coordinated nationallyrepresentative surveys:
1. a survey of households with at least
one resident child under the age of 13
(Household Interview),
ADDRESSES:
E:\FR\FM\04MYN1.SGM
04MYN1
Agencies
[Federal Register Volume 88, Number 86 (Thursday, May 4, 2023)]
[Notices]
[Pages 28554-28556]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09400]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-855A, CMS-R-246 and CMS-10823]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of
information, including each proposed extension or reinstatement of an
existing collection of information, and to allow a second opportunity
for public comment on the notice. Interested persons are invited to
send comments regarding the burden estimate or any
[[Page 28555]]
other aspect of this collection of information, including the necessity
and utility of the proposed information collection for the proper
performance of the agency's functions, the accuracy of the estimated
burden, ways to enhance the quality, utility, and clarity of the
information to be collected, and the use of automated collection
techniques or other forms of information technology to minimize the
information collection burden.
DATES: Comments on the collection(s) of information must be received by
the OMB desk officer by June 5, 2023.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. The term ``collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes agency requests or requirements that members of the public
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
federal agencies to publish a 30-day notice in the Federal Register
concerning each proposed collection of information, including each
proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice that
summarizes the following proposed collection(s) of information for
public comment:
1. Type of Information Collection Request: Reinstatement with
change of a previously approved collection; Title of Information
Collection: Medicare Enrollment Application for Institutional
Providers; Use: The primary function of the CMS-855A Medicare
enrollment application is to gather information from a certified
provider or certified supplier (hereafter occasionally and collectively
referenced as ``provider(s)'') that tells us who it is, whether it
meets certain qualifications to be a health care provider, where it
practices or renders services, the identity of its owners, and other
information necessary to establish correct claims payments. This
collection of information reinstatement request is associated in part
with our December 28, 2020 (85 FR 84472) final rule (CMS-1734-F, RIN
0938-AU10). The collection of information changes stemming from this
final rule were approved by OMB on September 28, 2021 (ICR Reference
No.: 202103-0938-010).
Existing Sec. 424.67 outlines a number of enrollment requirements
for opioid treatment programs (OTPs). One requirement, addressed in
Sec. 424.67(b)(1)(i), is that OTPs must maintain and submit to CMS a
list of all physicians, other eligible professionals, and pharmacists
who are legally authorized to prescribe, order, or dispense controlled
substances on the OTP's behalf; the list must include the person's
first and last name and middle initial, social security number,
National Provider Identifier, and license number (if applicable). This
reinstatement request will add these data elements to the CMS-855A,
which OTPs must complete if they wish to bill for OTP services via an
institutional claim form (specifically, the 837I).
On November 23, 2022, CMS published in the Federal Register a final
rule with comment period rule titled ``Medicare Program: Hospital
Outpatient Prospective Payment and Ambulatory Surgical Center Payment
Systems and Quality Reporting Programs; Organ Acquisition; Rural
Emergency Hospitals: Payment Policies, Conditions of Participation,
Provider Enrollment, Physician Self-Referral; New Service Category for
Hospital Outpatient Department Prior Authorization Process; Overall
Hospital Quality Star Rating; COVID-19'' (CMS-1772-FC) (87 FR 71748).
This final rule with comment period outlined requirements that rural
emergency hospitals (REHs)--a new Medicare provider type established
pursuant to Section 125 of Division CC of the Consolidated
Appropriations Act, 2021--must meet in order to bill Medicare for REH
services; in accordance with new section 1861(kkk) of the Social
Security Act, a facility is eligible to convert to an REH if it was a
critical access hospital (CAH) or rural hospital with less than 50 beds
as of December 27, 2020. CMS-1772-FC's REH requirements include those
necessary to enroll as an REH. The most pertinent of these is that a
CAH or rural hospital seeking REH enrollment submits a CMS-855A change
of information application and need not submit a full, initial CMS-855A
application. This reinstatement request will address the expected REH
burden associated with completing these CMS-855A changes of
information.
As part of this request, and as described in the supporting
statement, we also seek approval for additional changes to the CMS-
855A. These changes principally (though not exclusively) involve the
collection of information related to the provider's ownership.
Form Number: CMS-855A (OMB control number: 0938-0685); Frequency:
On occasion; Affected Public: Business or other for-profits, not-for-
profit institutions; Number of Respondents: 1,340; Total Annual
Responses: 5,881; Total Annual Hours: 72,147. (For policy questions
regarding this collection contact Frank Whelan at 410-786-1302.)
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare
Advantage, Medicare Part D, and Medicare Fee-For-Service Consumer
Assessment of Healthcare Providers and Systems (CAHPS) Survey; Use: CMS
is required to collect and report information on the quality of health
care services and prescription drug coverage available to persons
enrolled in a Medicare health or prescription drug plan under
provisions in the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA). Specifically, the MMA under Sec.
1860D-4 (Information to Facilitate Enrollment) requires CMS to conduct
consumer satisfaction surveys regarding Medicare prescription drug
plans and Medicare Advantage plans and report this information to
Medicare beneficiaries prior to the Medicare annual enrollment period.
The Medicare CAHPS survey meets the requirement of collecting and
publicly reporting consumer satisfaction information. The Balanced
Budget Act of 1997 also requires the collection of information about
fee-for-service plans.
The primary purpose of the Medicare CAHPS surveys is to provide
information to Medicare beneficiaries to help them make more informed
choices among health and prescription drug plans available to them.
Survey results are reported by CMS in the Medicare &
[[Page 28556]]
You Handbook published each fall and on the Medicare Plan Finder
website. Beneficiaries can compare CAHPS scores for each health and
drug plan as well as compare MA and FFS scores when making enrollment
decisions. The Medicare CAHPS also provides data to help CMS and others
monitor the quality and performance of Medicare health and prescription
drug plans and identify areas to improve the quality of care and
services provided to enrollees of these plans. CAHPS data are included
in the Medicare Part C & D Star Ratings and used to calculate MA
Quality Bonus Payments. Form Number: CMS-R-246 (OMB control number:
0938-0732); Frequency: Yearly; Affected Public: Individuals and
Households; Number of Respondents: 794,500; Total Annual Responses:
794,500; Total Annual Hours: 192,265. (For policy questions regarding
this collection contact Lauren Fuentes at 410-786-2290).
3. Type of Information Collection Request: New collection (Request
for new OMB control number); Title of Information Collection: End-stage
Renal Disease (ESRD) Quality Incentive Program (QIP): Study of Quality
and Patient Experience; Use: The Centers for Medicare & Medicaid
Services (CMS) oversees the quality of care provided by dialysis
facilities by administering the Quality Incentive Program (QIP). As
part of the evaluation of this program, CMS seeks to gain a deeper
understanding of emerging trends observed across the dialysis landscape
by conducting qualitative data collection and analysis. These primary
qualitative data collection activities seek to answer the following
research questions related to dialysis quality, access to care, health
equity, and quality of life:
1. What aspects of patient dialysis care do patients report as a
priority?
2. How, if at all, do dialysis facilities evaluate the quality of
care they provide?
3. What strategies do providers and dialysis facilities use to
improve access to care for underserved populations?
4. What do patients, providers, and stakeholder organizations
believe contributes to high quality of life for patients with ESRD? Do
perceptions vary by respondent type or respondent characteristics?
5. How do dialysis facilities measure patient satisfaction and
quality of life?
6. How do dialysis providers and stakeholder organizations think
quality of life for dialysis patients has changed over time? What was
the impetus for that change?
We are requesting to collect information through in depth
interviews with stakeholders of the CMS end-stage renal disease (ESRD)
Quality Incentive Program (QIP). The interviews will collect data from
individuals with ESRD, dialysis facility administrators, dialysis
social workers, transplant center administrators, corporate
representatives from dialysis organizations, and patient advocacy
organizations.
This data collection seeks to answer several research questions
specific to health outcomes for dialysis patients, as measured by the
QIP, that are not available through current literature or secondary
data collection. In preparation for this study, the evaluation team
conducted a scan of peer-reviewed literature and document review of
previous ESRD QIP monitoring and evaluation reports and policy
documents describing CMS priorities. Based on the results from this
scan, the study team identified persistent knowledge gaps and
opportunities for primary data collection. Drawing on high-quality
data, empirical rigor, and knowledge of nonprogrammatic factors, the
evaluation will benefit CMS by providing data-driven findings and
recommendations to improve patient care, reduce health disparities, and
promote health equity.
This primary data collection will allow CMS to more comprehensively
understand the data being compiled and analyzed quantitatively and will
provide more context related to dialysis quality, quality of life of
individuals with ESRD, access to dialysis care, and the patient
experience, which are current CMS priorities. Form Number: CMS-10823
(OMB control number: 0938-NEW); Frequency: Once; Affected Public:
Private Sector (Business or other for-profits, Not-for-Profit
Institutions), Individuals and Households; Number of Respondents:
1,945; Total Annual Responses: 1,945; Total Annual Hours: 604. (For
policy questions regarding this collection contact Christopher King at
(410) 786-6972).
Dated: April 28, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2023-09400 Filed 5-3-23; 8:45 am]
BILLING CODE 4120-01-P